These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 10727449)

  • 1. Genetic immunization of outbred mice with thyrotropin receptor cDNA provides a model of Graves' disease.
    Costagliola S; Many MC; Denef JF; Pohlenz J; Refetoff S; Vassart G
    J Clin Invest; 2000 Mar; 105(6):803-11. PubMed ID: 10727449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reevaluating thyrotropin receptor-induced mouse models of graves' disease and ophthalmopathy.
    Baker G; Mazziotti G; von Ruhland C; Ludgate M
    Endocrinology; 2005 Feb; 146(2):835-44. PubMed ID: 15542454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation and transfer of a murine model of thyrotropin receptor antibody mediated Graves' disease.
    Kita M; Ahmad L; Marians RC; Vlase H; Unger P; Graves PN; Davies TF
    Endocrinology; 1999 Mar; 140(3):1392-8. PubMed ID: 10067867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrasting activities of thyrotropin receptor antibodies in experimental models of Graves' disease induced by injection of transfected fibroblasts or deoxyribonucleic acid vaccination.
    Rao PV; Watson PF; Weetman AP; Carayanniotis G; Banga JP
    Endocrinology; 2003 Jan; 144(1):260-6. PubMed ID: 12488353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel murine model of Graves' hyperthyroidism with intramuscular injection of adenovirus expressing the thyrotropin receptor.
    Nagayama Y; Kita-Furuyama M; Ando T; Nakao K; Mizuguchi H; Hayakawa T; Eguchi K; Niwa M
    J Immunol; 2002 Mar; 168(6):2789-94. PubMed ID: 11884447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Graves' immunoglobulins activate phospholipase A2 by recognizing specific epitopes on thyrotropin receptor.
    Di Cerbo A; Di Paola R; Menzaghi C; De Filippis V; Tahara K; Corda D; Kohn LD
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3283-92. PubMed ID: 10487700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence and clinical significance of blocking thyrotropin receptor antibodies in untreated hyperthyroid Graves' disease.
    Kim WB; Chung HK; Park YJ; Park DJ; Tahara K; Kohn LD; Cho BY
    Thyroid; 2000 Jul; 10(7):579-86. PubMed ID: 10958310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An improved Graves' disease model established by using in vivo electroporation exhibited long-term immunity to hyperthyroidism in BALB/c mice.
    Kaneda T; Honda A; Hakozaki A; Fuse T; Muto A; Yoshida T
    Endocrinology; 2007 May; 148(5):2335-44. PubMed ID: 17255207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probing the genetic basis for thyrotropin receptor antibodies and hyperthyroidism in immunized CXB recombinant inbred mice.
    Aliesky HA; Pichurin PN; Chen CR; Williams RW; Rapoport B; McLachlan SM
    Endocrinology; 2006 Jun; 147(6):2789-800. PubMed ID: 16543368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of hyperthyroidism in mice by intradermal immunization with DNA encoding the thyrotropin receptor.
    Barrett K; Liakata E; Rao PV; Watson PF; Weetman AP; Lymberi P; Banga JP; Carayanniotis G
    Clin Exp Immunol; 2004 Jun; 136(3):413-22. PubMed ID: 15147342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of autoantibody-mediated Graves'-like hyperthyroidism in mice with IL-4, a Th2 cytokine.
    Nagayama Y; Mizuguchi H; Hayakawa T; Niwa M; McLachlan SM; Rapoport B
    J Immunol; 2003 Apr; 170(7):3522-7. PubMed ID: 12646613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TSH receptor-adenovirus-induced Graves' hyperthyroidism is attenuated in both interferon-gamma and interleukin-4 knockout mice; implications for the Th1/Th2 paradigm.
    Nagayama Y; Saitoh O; McLachlan SM; Rapoport B; Kano H; Kumazawa Y
    Clin Exp Immunol; 2004 Dec; 138(3):417-22. PubMed ID: 15544617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The link between Graves' disease and Hashimoto's thyroiditis: a role for regulatory T cells.
    McLachlan SM; Nagayama Y; Pichurin PN; Mizutori Y; Chen CR; Misharin A; Aliesky HA; Rapoport B
    Endocrinology; 2007 Dec; 148(12):5724-33. PubMed ID: 17823263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The formation of thyrotropin receptor (TSHR) antibodies in a Graves' animal model requires the N-terminal segment of the TSHR extracellular domain.
    Kikuoka S; Shimojo N; Yamaguchi KI; Watanabe Y; Hoshioka A; Hirai A; Saito Y; Tahara K; Kohn LD; Maruyama N; Kohno Y; Niimi H
    Endocrinology; 1998 Apr; 139(4):1891-8. PubMed ID: 9528975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Schistosoma mansoni and alpha-galactosylceramide: prophylactic effect of Th1 Immune suppression in a mouse model of Graves' hyperthyroidism.
    Nagayama Y; Watanabe K; Niwa M; McLachlan SM; Rapoport B
    J Immunol; 2004 Aug; 173(3):2167-73. PubMed ID: 15265954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that TSH Receptor A-Subunit Multimers, Not Monomers, Drive Antibody Affinity Maturation in Graves' Disease.
    Rapoport B; Aliesky HA; Chen CR; McLachlan SM
    J Clin Endocrinol Metab; 2015 Jun; 100(6):E871-5. PubMed ID: 25856215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of thyroid-stimulating hormone receptor autoimmunity in hamsters.
    Ando T; Imaizumi M; Graves P; Unger P; Davies TF
    Endocrinology; 2003 Feb; 144(2):671-80. PubMed ID: 12538630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid-stimulating monoclonal antibodies.
    Sanders J; Jeffreys J; Depraetere H; Richards T; Evans M; Kiddie A; Brereton K; Groenen M; Oda Y; Furmaniak J; Rees Smith B
    Thyroid; 2002 Dec; 12(12):1043-50. PubMed ID: 12593717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged TSH receptor A subunit immunization of female mice leads to a long-term model of Graves' disease, tachycardia, and cardiac hypertrophy.
    Holthoff HP; Goebel S; Li Z; Faßbender J; Reimann A; Zeibig S; Lohse MJ; Münch G; Ungerer M
    Endocrinology; 2015 Apr; 156(4):1577-89. PubMed ID: 25562617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental model for ophthalmopathy in BALB/c and outbred (CD-1) mice genetically immunized with G2s and the thyrotropin receptor.
    Yamada M; Li AW; West KA; Chang CH; Wall JR
    Autoimmunity; 2002 Sep; 35(6):403-13. PubMed ID: 12568121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.